Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1309"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1182"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_Tracable_Statement
?:content	"The FDA recommends debrisoquine to be an acceptable chemical CYP2D6 substrate (CYP2D6-->(debrisoquine->4-OH-debrisoquine)) for in vitro experiments in it most recent guidance document. See Table 3, p. 32"
dc:creator	"boycer"
dc:date	"05/06/2009 12:50:59"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ cyp2d6_controls_formation_of_4-hydroxydebrisoquine, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1182 }

Context graph